We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanders, Cummings Launch Congressional Investigation into Marathon’s $89,000 Drug
Sanders, Cummings Launch Congressional Investigation into Marathon’s $89,000 Drug
Two congressmen sent a letter to the CEO of Marathon Pharmaceuticals, calling the company’s decision to market an old drug for Duchenne muscular dystrophy for $89,000 per year as “outrageous” and “unconscionable.”